MORGAN STANLEY - TRINITY BIOTECH PLC ownership

TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 25 filers reported holding TRINITY BIOTECH PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of TRINITY BIOTECH PLC
ValueSharesWeighting
Q3 2023$10,698
-70.6%
14,552
-61.9%
0.00%
Q2 2023$36,364
+1.2%
38,2330.0%0.00%
Q1 2023$35,939
-6.5%
38,233
-1.5%
0.00%
Q4 2022$38,445
-19.9%
38,833
-13.3%
0.00%
Q3 2022$48,000
-15.8%
44,783
-4.7%
0.00%
Q2 2022$57,000
-50.4%
46,983
-56.4%
0.00%
Q1 2022$115,000
+32.2%
107,856
+78.0%
0.00%
Q4 2021$87,000
+93.3%
60,608
+191.9%
0.00%
Q3 2021$45,000
+4.7%
20,765
+40.0%
0.00%
Q2 2021$43,000
-89.7%
14,833
-86.7%
0.00%
Q1 2021$419,000
-49.7%
111,489
-49.0%
0.00%
Q4 2020$833,000
+64.0%
218,689
-13.0%
0.00%
Q3 2020$508,000
+21.8%
251,317
+31.2%
0.00%
Q2 2020$417,000
+561.9%
191,501
+232.1%
0.00%
Q1 2020$63,000
-86.7%
57,661
-87.5%
0.00%
Q4 2019$475,000
-14.9%
459,527
-0.3%
0.00%
Q3 2019$558,000
-26.7%
460,727
-0.0%
0.00%
Q2 2019$761,000
-42.6%
460,852
-0.9%
0.00%
Q1 2019$1,326,000
+24.6%
465,268
+0.1%
0.00%
Q4 2018$1,064,000
-42.9%
465,035
-0.2%
0.00%
Q3 2018$1,864,000
-20.1%
465,848
-0.2%
0.00%
-100.0%
Q2 2018$2,334,000
-2.8%
466,692
+0.1%
0.00%0.0%
Q1 2018$2,400,000
+0.8%
466,078
-0.1%
0.00%0.0%
Q4 2017$2,380,000
+166.2%
466,595
+193.0%
0.00%
Q3 2017$894,000
+2454.3%
159,253
+2560.4%
0.00%
Q2 2017$35,000
-52.7%
5,986
-50.7%
0.00%
Q1 2017$74,000
-26.0%
12,150
-16.5%
0.00%
Q4 2016$100,000
-50.5%
14,548
-5.2%
0.00%
Q3 2016$202,000
+21.7%
15,345
+4.5%
0.00%
Q2 2016$166,000
-47.3%
14,682
-45.7%
0.00%
Q1 2016$315,000
-6.5%
27,048
-5.4%
0.00%
Q4 2015$337,000
-11.8%
28,607
-14.3%
0.00%
Q3 2015$382,000
-33.9%
33,386
+4.6%
0.00%
Q2 2015$578,000
+19.2%
31,932
+26.9%
0.00%
Q1 2015$485,000
-20.8%
25,155
-28.0%
0.00%
Q4 2014$612,000
-27.6%
34,918
-24.5%
0.00%
Q3 2014$845,000
-56.0%
46,250
-44.6%
0.00%
-100.0%
Q2 2014$1,922,000
+6.5%
83,469
+12.0%
0.00%0.0%
Q1 2014$1,805,000
-0.6%
74,510
+3.2%
0.00%0.0%
Q4 2013$1,815,000
+16.9%
72,206
+1.2%
0.00%0.0%
Q3 2013$1,553,000
+44.6%
71,345
+12.0%
0.00%0.0%
Q2 2013$1,074,00063,7150.00%
Other shareholders
TRINITY BIOTECH PLC shareholders Q1 2022
NameSharesValueWeighting ↓
ACK Asset Management 657,100$11,072,0004.49%
GOLDMAN CAPITAL MANAGEMENT INC 343,000$5,780,0003.30%
Lyon Street Capital, LLC 368,858$6,215,257,0003.08%
JAY JEFFREY R 163,140$2,749,0002.17%
Adirondack Research & Management Inc. 161,507$2,721,0002.03%
Park West Asset Management LLC 448,415$7,556,0000.89%
Benchmark Capital Advisors 51,600$869,0000.67%
SHEPHERD KAPLAN KROCHUK, LLC 166,034$2,797,0000.55%
HEARTLAND ADVISORS INC 1,569,699$26,449,0000.49%
WOODMONT INVESTMENT COUNSEL LLC 86,682$1,461,0000.49%
View complete list of TRINITY BIOTECH PLC shareholders